MedTrace Logo

An Evaluation of Omega-3 Fatty Acid

NCT03017651 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-05-16

No results posted yet for this study

Summary

This protocol will determine the pK profile of two different omega-3 fatty acid supplements on plasma EPA and DHA levels.

Conditions

  • Overweight and Obesity

Interventions

DIETARY_SUPPLEMENT

OM3-supplement 1

1g of OM3-supplement 1 will be given to subjects to look at DHA/EPA blood absorption

DIETARY_SUPPLEMENT

OM3-supplement 2

1g of OM3-supplement 2 will be given to subjects to look at DHA/EPA blood absorption

Sponsors & Collaborators

  • Miami Research Associates

    collaborator NETWORK

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Diane Krieger, MD · QPS-MRA

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2016-12-31
Completion
2017-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03017651 on ClinicalTrials.gov